InterventionsHuman trial
Efficacy and Safety of Extended-Interval PG-102, a GLP-1/GLP-2 Bispecific Agonist, in Adults with Type 2 Diabetes
ADA Scientific Sessions 2026 Abstract
The paper
KIM SW, YANG SI, KIM J et al.
ADA Scientific Sessions 2026 Abstract · 5 Jun 2026
Presented at ADA Scientific Sessions 2026 · Late-breaking 2823-LB